Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults
- PMID: 29718904
- PMCID: PMC5931494
- DOI: 10.1371/journal.pmed.1002566
Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults
Abstract
Background: Observational studies have reported that higher plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with lower risks of diabetes, but it is unclear if these associations are causal. The aim of this study was to test the relevance of 25(OH)D for type 2 diabetes using genetically instrumented differences in plasma 25(OH)D concentrations.
Methods and findings: Data were available on four 25(OH)D single nucleotide polymorphisms (SNPs; n = 82,464), plasma 25(OH)D concentrations (n = 13,565), and cases with diabetes (n = 5,565) in the China Kadoorie Biobank (CKB). The effects on risk of diabetes were assessed by a genetic score using two 25(OH)D synthesis SNPs (DHCR7-rs12785878 and CYP2R1-rs10741657), with and without the addition of SNPs affecting the transport (GC/DBP-rs2282679) and catabolism (CYP24A1-rs6013897) of 25(OH)D. The CKB results were combined in a meta-analysis of 10 studies for the 2 synthesis SNPs (n = 58,312 cases) and 7 studies for all 4 SNPs (n = 32,796 cases). Mean (SD) 25(OH)D concentration was 62 (20) nmol/l in CKB, and the per allele effects of genetic scores on 25(OH)D were 2.87 (SE 0.39) for the synthesis SNPs and 3.54 (SE 0.32) for all SNPs. A 25-nmol/l higher biochemically measured 25(OH)D was associated with a 9% (95% CI: 0%-18%) lower risk of diabetes in CKB. In a meta-analysis of all studies, a 25-nmol/l higher genetically instrumented 25(OH)D concentration was associated with a 14% (95% CI: 3%-23%) lower risk of diabetes (p = 0.01) using the 2 synthesis SNPs. An equivalent difference in 25(OH)D using a genetic score with 4 SNPs was not significantly associated with diabetes (odds ratio 8%, 95% CI: -1% to 16%, lower risk, p = 0.07), but had some evidence of pleiotropy. A limitation of the meta-analysis was the access only to study level rather than individual level data.
Conclusions: The concordant risks of diabetes for biochemically measured and genetically instrumented differences in 25(OH)D using synthesis SNPs provide evidence for a causal effect of higher 25(OH)D for prevention of diabetes.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: MIM serves on Advisory Panels for Pfizer and NovoNordisk, and has received honoraria from Pfizer, Eli Lilly and NovoNordisk. He receives research funding from Pfizer, Eli Lilly, NovoNordisk, Merck, Takeda, Janssen, Servier, Sanofi-Aventis, Astra Zeneca, Roche, and Boehringer Ingelheim.
Figures
References
-
- Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2014;42:698–702. doi: 10.1016/j.mpmed.2014.09.007 - DOI - PMC - PubMed
-
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81. doi: 10.1056/NEJMra070553 - DOI - PubMed
-
- Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S–88S. - PubMed
-
- Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278–83. doi: 10.2337/dc09-0209 - DOI - PMC - PubMed
-
- Ye Z, Sharp SJ, Burgess S, Scott RA, Imamura F, InterAct Consortium, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a Mendelian randomisation study. Lancet Diabetes Endocrinol. 2015;3:35–42. doi: 10.1016/S2213-8587(14)70184-6 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MC_U137686851/MRC_/Medical Research Council/United Kingdom
- FS/18/23/33512/BHF_/British Heart Foundation/United Kingdom
- 212946/Z/18/Z/WT_/Wellcome Trust/United Kingdom
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- MC_UU_12026/2/MRC_/Medical Research Council/United Kingdom
- PG/12/32/29544/BHF_/British Heart Foundation/United Kingdom
- MC_PC_14135/MRC_/Medical Research Council/United Kingdom
- 088158/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- 098381/WT_/Wellcome Trust/United Kingdom
- 104085/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- MC_U137686855/MRC_/Medical Research Council/United Kingdom
- MC_PC_13049/MRC_/Medical Research Council/United Kingdom
- 202922/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- MC-PC-14135/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
